Intelligent Bio Solutions Accounts Payable

Intelligent Bio Solutions (INBS) currently reports a accounts payable of $710K as of June 2026. That compares with $900K in the prior-year period — down 20.6% year over year. Use the charts on this page to explore Intelligent Bio Solutions's accounts payable history and peer comparisons.

Intelligent Bio Solutions's accounts payable decreased from $900K to $710K — a 20.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Intelligent Bio Solutions reported $710K in accounts payable as of June 2026. That compares with $900K in the prior-year period — down 20.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $710K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Intelligent Bio Solutions, and consider following INBS for alerts when major investors trade the stock.

Intelligent Bio Solutions is classified in the Healthcare sector. On accounts payable, it currently shows $710K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INBS with unrelated industries.